All About Alzheimer's Caring Conversations
For the first time, drugs targeting amyloid plaques have moved beyond trials and into real world use. Treatments like Kisunla and Leqembi, approved in 2023 and 2024, have helped validate the long debated amyloid theory.
13 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de All About Alzheimer's Caring Conversations!